News

New technique protects 'architecture' of insulin-producing islet cells for transplant into type 1 diabetics
Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...
Retatrutide (LY3437943): A Novel Tri-agonist Peptide for Metabolic Disease Treatment
TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...
From diet to drugs: What really works for long-term weight loss
More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...
The Cardiology Advisor4h
Glargine U300 Safe in Across All CKD Stages in Type 2 Diabetes
Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.
Mirage News2h
Diet Vs. Drugs: Keys to Long-Term Weight Loss
More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health Organization. This staggering ...
Informationsdienst Wissenschaft7h
GIP Receptor: Activation and Blockade Support Weight Loss
Home > Pressemitteilung: GIP Receptor: Activation and Blockade ...
Health and Me on MSN22h
Novo Nordisk Launches Weight Loss Drug Wegovy In Thailand
Wegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...
latestnewsandupdates.com21h
Orforglipron, the first oral drug for obesity and diabetes is coming
ORforglipron is a Experimental drug a small (non-peptide) oral agonist of the GLP-1 receptor oral, which does not require ...